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Assessment of Gene-Association Studies on Matrix Metalloproteinase Gene Family 
Polymorphisms in Association to the Pathogenesis of Intracranial Aneurysms Using The 
STREGA checklist: A Quality Review 
Abstract 
Background/Objectives:The role of matrix-metalloproteinase gene-family 
polymorphisms in the pathogenesis of the intracranial aneurysms hasnot been clearly 
established. Aim of the current study is to assess the transparency and reporting qualityof the 
medical literature focusing on role of matrix-metalloproteinase gene-family polymorphisms in 
the pathogenesis of the intracranial aneurysms. 
Methods: We performed a qualityreview of gene association studiesfocusing the role of 
matrix-metalloproteinase gene-family polymorphismsas potential risk factors for intracranial 
aneurysms. The search was limited to English-written studies on adults. Two independent 
reviewers classified the gathered articles into “High”, “Medium” and “Low”quality study 
reports, in terms of reporting transparency and completeness, using the STREGA checklist. 
The publication year, the journal’s impact factor, the hosting country and the existence of 
fundingwere regarded as potential confounders. Comparison of the data between-groups was 
evaluated usingthe chi-square or Fisher’ s test, as appropriate. 
Results:A total of eight studies (2716 cases and 3569 controls) fulfilled our eligibility 
criteria and were included in this review. Nineteen polymorphisms involving five matrix-
metalloproteinases (MMP-1, -2, -3, -9 and -12) were studied is association to intracranial 
aneurysms and/or subarachnoid hemorrhage. Sevenstudies were characterized as of “Medium” 
reporting quality, while the remaining one was classified as “Low”. The publication year, the 
journal’s impact factor, the hosting country and the existence of funding had no impact on the 
reporting quality. 
Conclusions: The reporting quality in terms of completeness and transparency of gene-
association studies focusing on the role of matrix-metalloproteinase gene-family 
polymorphism in the pathogenesis of intracranial aneurysms is moderate to low. Adherence to 
checklists, such as STREGA, is expected to lead the way towards high quality studies and 
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transparent meta-analyses. 
Keywords:GAS, gene polymorphisms, MMP, intracranial aneurysm, subarachnoid 
hemorrhage, STREGA 
 
Abbreviations:HWE: Hardy-Weinberg equilibrium, GAS: gene association studies, IA: 
intracranial aneurysms, MMP: metalloproteinases, SNP: single nucleotide polymorphisms, 
STREGA: Strengthening The REporting of Genetic Association studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 12:27:36 EET - 137.108.70.7
 9 
1. Introduction 
Intracranial aneurysms (IA) are the most common cause of spontaneous subarachnoid 
hemorrhage. They are associated with high morbidity and mortality rates.Their estimated 
prevalence has been reported to be as high as 2% of the general population[1]. Rupture of an 
intracranial aneurysm is a major neurosurgical emergency, which is characterized by a high re-
bleeding rate, and might be complicated by a number of clinical entities that include and are 
not limited to permanent neurological deficit, vasospasm, seizures, hydrocephalus, electrolytic 
imbalances and electrocardiographic changes[2]. IA can occur either sporadically or might 
cluster in families[3].  
The pathophysiology behind the development and rupture of the IA is not fully 
understood. It is assumed that there is a good interplay between a number of appreciated risk 
factors (hypertension, cigarette smoking, alcohol consumption and female sex) and genetic 
predisposition[4]. Familial occurrence of IA has been documented in association with 
hereditary disorders, such as polycystic kidney disease and Ehles-Danlos syndrome[3]. On the 
other hand, little is known about the genetic background of sporadic aneurysms[5]. Recent 
studies have focused on the degradation and remodeling process of the blood vessels, and their 
related genetic polymorphisms[6, 7]. Matrix-metalloproteinases (MMP), a group of 22 zinc-
dependent proteins that carry a pivotal role in the degradation of collagen matrix proteins, have 
attracted a great deal of attention, especially in the pathophysiology of abdominal 
aneurysms[8, 9].  
In the current communication we performed a literature review on gene association 
studies that deal with MMP gene-family polymorphisms in association to IA and/or 
subarachnoid hemorrhage in adults. Our goal is to study the quality of the reported articles in 
terms of transparency and completeness of reporting using an extension of the STROBE 
statement, known as STREGA[10]. This is the first step in a lengthy process of best-evidence 
synthesis, with an ultimate goal to prevent and treat this clinical entity.  
 
2. Methods 
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2.1 Publication search 
We performed an electronic database search at the following medical databases: 
PubMed, Scopus, and HuGE Navigator. The search terms included: “gene associations” or 
“gene-linkage analysis” or “GAS” or “polymorphisms” AND “intracranial aneurysm*” or 
“subarachnoid hemorrhage” AND “MMP-*” or “metalloproteinases*”. The titles and abstracts 
of the gathered articles were retrieved and controlled for relevance and irrelevant articles were 
excluded. The full-text of the remaining articles were retrieved and further controlled for 
relevance. Additional articles were supplemented from the reference list of the full-text 
articles.  
2.2 Eligibility criteria 
The search was limited in observational studies (cohort, case-control, and cross-sectional 
studies), written in English, and focusing on adult human subjects. We excluded laboratory 
studies, studies with insufficient data or with family-based design. Similarly, we 
excludedduplicates, personal communications, systematics reviews, meta-analyses, and 
editorials.The flowchart of the literature search is depicted on Figure 1. 
2.3 Quality Evaluation 
Two independent reviewers (AGB and CD)assessed the reporting quality of the gathered 
articles in terms of transparency and completeness, using the STREGA checklist. The latter, in 
addition to the 22 questions of the STROBE statement, highlights specific aspects of gene 
association studies, such as population structure, genotyping errors, modeling haplotype 
variation, Hardy-Weinberg equilibrium (HWE), and replication. Each item wasscored a best-
fitting value among “Yes”, “No”, or “NA” (Not Applicable)to evaluate for adherence to the 
STREGA checklist. A summative score represented the total endorsement of each item 
separately. 
In addition, a summary score was given to each study, representing the study’s 
adherence to transparent and high-quality reporting. Studies with scores ranging from 15 to 22 
were considered as “High” quality, 8-14 as “Medium” quality, and 0-7 as “Low” quality. It has 
to be clarified that the above-mentioned classification does not refer to the scientific value of 
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the study.  
2.4 Data Extraction 
Thefollowing data were collected: 1) the name of the first author, the year of 
publication, the journal’s impact factor, 2) the hosting country and the ethnicity of the 
participants, 3) the number of cases and controls, and 4) the SNPs under study. Journals with 
impact factor >10 were regarded as “High” impact-factor journals, while those with values 
between 10-3 and <3 were considered as “Medium” and “Low” impact-factor journals, 
respectively.  
Furthermore, we evaluated the adherence tothe STREGA checklist items, and 
categorized the questions as highly endorsed questions (endorsement-rate ranging between 67-
100%), moderately endorsed (34-66%), and inadequately-endorsed items (0-33%). 
2.5 ConfoundersandBias Elimination 
In order to eliminate the effect of confounding factors we stratified our results in terms 
ofyear of publication (before or after the publication of STREGA in 2009), the journals impact 
factor,the hosting country,and the funding. 
Moreover, the reviewers were blinded to the author’s name and journalto avoid 
information bias. Both reviewers received proper training in thechecklists, STROBE and 
STREGA. Each reviewer assessed the studies independently. In the case of disagreement 
between the two reviewers there was detailed discussion between them until both agreed to a 
common score. 
2.6Statistical Analysis 
Simple descriptive statistics were adopted for the realization of the current study using 
the statistical software “R”.Between groups analysis was performed usingthe chi-square or 
Fisher’ s test, as appropriate. 
 
3.Results 
 3.1 Literature Review 
 The literature search identified 63 articles. An additional study was found from the 
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reference list of the gathered articles. Thirty articles remained after duplicate removal. Thirteen 
articles were recognized as irrelevant after title and abstract review. Other 9 articles were of 
irrelevant context or methodology, and as such were eliminated from the qualitative analysis. 
One study without genotype distribution was considered not suitable for data synthesis. A total 
of eight studies[11-18] with 2716 cases and 3569 controls were included in this review (Figure 
1). 
3.2MMP-Family Gene Polymorphisms and IAs 
Nineteen polymorphisms from five MMP-genes (MMP-1, -2, -3, -9 and -12) were 
studied is association to IA and/or subarachnoid hemorrhage. The most commonly studied 
MMP gene-family polymorphisms were related to MMP-9, followed by MMP-3. Similarly, 
articles related to IA outnumber those related to “subarachnoid hemorrhage”, with 7 to 1. 
Three studies were performed in a mixed White European American/Black African American 
population, four in Caucasians, and one in Japanese (Table 1). 
3.3Endorsement of STREGA and Reporting Quality 
Items Q.1, Q.2, Q.4, Q.5, Q.20, and Q.22 were highly endorsed, while items Q.3, Q.7, 
Q.9, Q.10, Q.12, Q.13, Q.14, Q.16, Q.17, and Q.21belonged among the least commented 
arguments (low-endorsement). Items Q.6, Q.8, Q.11, Q.15, Q.19 were assessed as moderately 
endorsed topics(Table 2). All items in the “Title and abstract” and “Other” sections carry a 
low risk of reporting bias. On the contrary, more than 70% of the items in each of the sections 
under the headings of  “Methods”, “Results” and “Discussion” indicate potential sources of 
bias (Figure 2).    
The median score of the gathered articles was 9.5 (range: 7-14). No study addressed all 
items of the STREGA checklist, or was categorized as a “High” qualitystudy. Seven studies 
were characterized asof “Medium” reporting quality according to STREGA checklist, while 
the remaining one was classified as “Low”.  
3.4Effect of Confounders 
The gathered articles were published in the period between 1999 and 2011. There was 
no statistically important difference in the quality of reported studies before and after the 
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release of STREGA (p=0.531).  
No study was published in a “High” impact-factor journal (>10). “Medium” and 
“Low” impact-factor journals hosted five and three studies, respectively (Table 1). Among the 
seven studies of moderate quality, five have been published in medium impact factor journals, 
and the remaining two in low impact factor journals. Finally, one low quality study was 
published in a low impact factor journal. We could not identify a statistically significant role of 
the journal’s impact-factor on the article’s reporting quality (p=0.168).  
Three studies took place in the USA, three in Europe and one in Asia. There was no 
statistically important effect of the hosting country (p=0.135) or the existence of funding on 
the reporting quality of the studies (p=0.64). 
 
4.Discussion 
4.1 Overview of the Study Findings 
To the best of our knowledge this is the first quality review of studies reporting on 
MMP-family gene polymorphisms in association to IA or subarachnoid hemorrhage. Eight 
articles fulfilled our eligibility criteria[11-18]. The majority of the gathered articles were of 
medium reporting quality. It became clear that the adherence to the STREGA checklist is 
moderate. MMP-9 and MMP-3 gene polymorphisms were the most studied as potential risk 
factors ofIA pathogenesis or rupture. The small number of articles precluded the use of 
inferential statistics. 
4.2 Correlation with Other Studies 
The association of MMP-family gene polymorphisms and abdominal aneurysm, 
myocardial infraction and ischemic stroke has extensively been studied. A meta-analysis by 
Wen et al., showed that MMP-1 -1607 1G/2G andMMP-3 -1612 5A/6A were risk factors for 
ischemic stroke,while MMP-9 -1562C/T was not associated with ischemicstroke[19].Juan et 
al., reportedthatthe MMP9 -1562C/Tpolymorphismisariskfactorassociatedwith increased 
myocardial infarction susceptibilityinthetotalpopulationand in 
whitepopulations,althoughnosignificant associationwasobservedin Asian populations[20]. 
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Similarly, Morris et al., revealed that a common SNP within the MMP3 promoter region, 
previously suggested to increase MMP3 expression, appears to be a moderate risk factor for 
abdominal aortic aneurysms[8]. However, the evidence in not clear enough when it comes 
toMMP gene-family polymorphisms and IA[11-18]. 
4.3 Reporting Gaps According toSTREGA 
Our analysis revealed that reporting of GAS forMMP-family gene polymorphisms as 
potential risk factors in the pathogenesis and rupture ofIA moderately adhere to STREGA. We 
noticed a systematic failure to comply with particular items, especially in the “Methods” and 
the “Results” section. The gathered articles did not clearly state if the study was the first report 
of GAS, a replication or both (Q.3). The authors failed to address potential confounders and 
bias (Q.7, Q.9) or justify the size of their sample (Q.10). No article achieved to fully reportits 
statistical analysis, as mandated by STREGA (Q.12). There was no reporting on the number of 
individuals in whom genotyping was attempted and number of individuals in whom 
genotyping was achieved (Q.13). At the same time, there was total absence ofreference to 
missing data (Q.14),adjustment to confounders/multiple comparisons (Q.16), and other 
analyses performed (subgroup-, interaction-, and sensitivity analysis, Q.17).Equally 
important,there was lack of reference to study limitations (Q.19) and the generalizabilityof the 
results in the “Discussion” section (Q.21). 
4.4 MediumandLow Quality Studies 
Seven articles were classified as “Medium” quality [11, 13-15, 17, 21, 22] and one as 
“Low” quality. Low et al., in an interesting article, studied the impact of LIMK-1, MMP-2 and 
TNF-α variations forΙΑ in Japanese population (2050 IA patients and 1853 controls from the 
Biobank Japan). The authors failed to conform to all but two of the reporting recommendations 
in the “Methods” section and all the recommendations in the “Results” section[18]. There was 
no evidence for confounding effect in respect of the publication year;the journal’s impact 
factor; the presence of funding, and the hosting country. 
4.5Limitations 
The current study has some important limitations. To start with, it is based on a small 
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number of studies, especially in the post-STREGA era, that do not allow us to perform 
statistical analysis. In addition, the research study was limited in English-written articles and in 
adults so we might have important effects from selection bias. 
In addition, the study might include information (allocation) bias. STREGA is a 
checklist that allows us to roughly evaluate the reporting quality of the gathered studies.  
However, it is a consortium product rather than a validated tool. As a result it lacks sensitivity 
and specificity evaluation. Moreover, not all items are of equal importance and special weight, 
therefore a summative score might not be representative of the reality. Thus, the current study 
is limited by these inherent characteristics of STREGA checklist. 
Another measure of the quality of the gene association studies is the Hardy-Weinberg 
equilibrium (HWE). The use of HWE quality control is expected to further limit the gathered 
studies, as the study of Kaplan et al., does not provide the HWE values[16].The present review 
did not adopt the HWE as quality measure, as it did not intent to proceed further in quantitative 
analysis. 
Furthermore, this review is exposed to publication bias, as we did not perform the 
relevant analysis (funnel plots and Egger’s test) at the context of a quality control study. 
4.6Future Recommendations 
As mentioned above, the number of studies on the association of MMP family gene 
polymorphisms to IA is limited. More replicate studies are needed, both in the same and in 
different populations so as to allow for further quantitative analysis through a meta-analysis.  
 
5. Conclusions 
The reporting quality in terms of completeness and transparency of gene-association 
studies on the role of MMP gene-family polymorphisms on the pathogenesis of intracranial 
aneurysms is moderate to low. Adherence to checklists such as STREGA is expected to lead 
the way towards high-quality studies and transparent meta-analysis. The later forms the corner 
stone of personalized prevention and treatment of the lethal clinical entity related to IA 
rupture. 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 12:27:36 EET - 137.108.70.7
 16 
 
 
 
References 
1. Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of 
intracranial aneurysms: a systematic review. Stroke. 1998;29(1):251-6. PubMed 
PMID: 9445359. 
2. Juvela S, Porras M, Poussa K. Natural history of unruptured intracranial 
aneurysms: probability of and risk factors for aneurysm rupture. J Neurosurg. 
2008;108(5):1052-60. doi: 10.3171/JNS/2008/108/5/1052. PubMed PMID: 18447733. 
3. Schievink WI, Schaid DJ, Michels VV, Piepgras DG. Familial aneurysmal 
subarachnoid hemorrhage: a community-based study. J Neurosurg. 1995;83(3):426-9. 
doi: 10.3171/jns.1995.83.3.0426. PubMed PMID: 7666217. 
4. Backes D, Rinkel GJ, Laban KG, Algra A, Vergouwen MD. Patient- and 
Aneurysm-Specific Risk Factors for Intracranial Aneurysm Growth: A Systematic 
Review and Meta-Analysis. Stroke. 2016;47(4):951-7. doi: 
10.1161/STROKEAHA.115.012162. PubMed PMID: 26906920. 
5. Mensing LA, Rinkel GJ, Vlak MH, van der Schaaf IC, Ruigrok YM. 
Difference in Aneurysm Characteristics between Patients with Familial and Sporadic 
Aneurysmal Subarachnoid Haemorrhage. PLoS One. 2016;11(4):e0154281. doi: 
10.1371/journal.pone.0154281. PubMed PMID: 27112915; PubMed Central PMCID: 
PMCPMC4841589. 
6. Nagase H, Visse R, Murphy G. Structure and function of matrix 
metalloproteinases and TIMPs. Cardiovasc Res. 2006;69(3):562-73. doi: 
10.1016/j.cardiores.2005.12.002. PubMed PMID: 16405877. 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 12:27:36 EET - 137.108.70.7
 17 
7. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of 
metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827-
39. doi: 10.1161/01.RES.0000070112.80711.3D. PubMed PMID: 12730128. 
8. Morris DR, Biros E, Cronin O, Kuivaniemi H, Golledge J. The association of 
genetic variants of matrix metalloproteinases with abdominal aortic aneurysm: a 
systematic review and meta-analysis. Heart. 2014;100(4):295-302. doi: 
10.1136/heartjnl-2013-304129. PubMed PMID: 23813847. 
9. Takagi H, Manabe H, Kawai N, Goto SN, Umemoto T. Circulating matrix 
metalloproteinase-9 concentrations and abdominal aortic aneurysm presence: a meta-
analysis. Interact Cardiovasc Thorac Surg. 2009;9(3):437-40. doi: 
10.1510/icvts.2009.208835. PubMed PMID: 19525292. 
10. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, et al. 
Strengthening the reporting of genetic association studies (STREGA): an extension of 
the STROBE statement. Eur J Epidemiol. 2009;24(1):37-55. doi: 10.1007/s10654-008-
9302-y. PubMed PMID: 19189221; PubMed Central PMCID: PMCPMC2764094. 
11. Peters DG, Kassam A, St Jean PL, Yonas H, Ferrell RE. Functional 
polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for 
intracranial aneurysm. Stroke. 1999;30(12):2612-6. PubMed PMID: 10582986. 
12. Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H. 
Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal 
aortic or intracranial aneurysms. Biochem Biophys Res Commun. 1999;265(2):563-8. 
doi: 10.1006/bbrc.1999.1721. PubMed PMID: 10558909. 
13. Zhang B, Dhillon S, Geary I, Howell WM, Iannotti F, Day IN, et al. 
Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to 
subarachnoid hemorrhage. Stroke. 2001;32(9):2198-202. PubMed PMID: 11546917. 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 12:27:36 EET - 137.108.70.7
 18 
14. Krex D, Kotteck K, König IR, Ziegler A, Schackert HK, Schackert G. Matrix 
metalloproteinase-9 coding sequence single-nucleotide polymorphisms in caucasians 
with intracranial aneurysms. Neurosurgery. 2004;55(1):207-12; discussion 12-3. 
PubMed PMID: 15214991. 
15. Pannu H, Kim DH, Guo D, King TM, Van Ginhoven G, Chin T, et al. The role 
of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms. J 
Neurosurg. 2006;105(3):418-23. doi: 10.3171/jns.2006.105.3.418. PubMed PMID: 
16961137. 
16. Kaplan RC, Smith NL, Zucker S, Heckbert SR, Rice K, Psaty BM. Matrix 
metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, 
ischemic stroke, and hemorrhagic stroke. Atherosclerosis. 2008;201(1):130-7. doi: 
10.1016/j.atherosclerosis.2008.01.003. PubMed PMID: 18342317; PubMed Central 
PMCID: PMCPMC3077423. 
17. Szczudlik P, Borratyńska A. Association between the -1562 C/T MMP-9 
polymorphism and cerebrovascular disease in a Polish population. Neurol Neurochir 
Pol. 2010;44(4):350-7. PubMed PMID: 20827608. 
18. Low SK, Zembutsu H, Takahashi A, Kamatani N, Cha PC, Hosono N, et al. 
Impact of LIMK1, MMP2 and TNF-α variations for intracranial aneurysm in Japanese 
population. J Hum Genet. 2011;56(3):211-6. doi: 10.1038/jhg.2010.169. PubMed 
PMID: 21228795. 
19. Wen D, Du X, Nie SP, Dong JZ, Ma CS. Association between matrix 
metalloproteinase family gene polymorphisms and ischemic stroke: a meta-analysis. 
Mol Neurobiol. 2014;50(3):979-85. doi: 10.1007/s12035-014-8687-8. PubMed PMID: 
24771042. 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 12:27:36 EET - 137.108.70.7
 19 
20. Juan Z, Wei-Guo Z, Heng-Liang S, Da-Guo W. Association of Matrix 
Metalloproteinase 9 C-1562T Polymorphism with Genetic Susceptibility to Myocardial 
Infarction: A Meta-Analysis. Curr Ther Res Clin Exp. 2015;77:40-5. doi: 
10.1016/j.curtheres.2014.05.001. PubMed PMID: 26082814; PubMed Central PMCID: 
PMCPMC4461879. 
21. Hilibrand AS, Carlson GD, Palumbo MA, Jones PK, Bohlman HH. 
Radiculopathy and myelopathy at segments adjacent to the site of a previous anterior 
cervical arthrodesis. J Bone Joint Surg Am. 1999;81(4):519-28. PubMed PMID: 
10225797. 
22. Mueller CA, Peters I, Podlogar M, Kovacs A, Urbach H, Schaller K, et al. 
Vertebral artery injuries following cervical spine trauma: a prospective observational 
study. Eur Spine J. 2011;20(12):2202-9. doi: 10.1007/s00586-011-1887-2. PubMed 
PMID: 21717238; PubMed Central PMCID: PMCPMC3229739. 
 
 
 
 
 
 
 
 
 
 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 12:27:36 EET - 137.108.70.7
 20 
Appendix 
Table 1.Overview of GAS
a
 on intracranial aneurysms and MMP gene family 
polymorphism. 
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 Impact 
Factor 
(Class) 
Country / 
Ethnicity 
Clinical 
Entity 
Study 
Design 
Genotyping Cases / 
Controls 
Reporting 
Quality 
according to 
STREGA  
MMP 
gene 
Polymorphisms 
Peters et al. 
(1999) [11] 
5.787 
(Medium) 
USA / Mixed 
European 
White 
Americans 
IA PC PCR 76/93 Medium MMP-9 Microsatellite 
repeats (CA)n 
Yoon et al. 
(1999) [12] 
 2.371 
(Low) 
Finland / 
Caucasian 
fIA PC PCR 57/174 Medium MMP-3 5A/5A  
MMP-9 Microsatellite 
repeats (CA)n 
Zhang et al. 
(2001) [13] 
5.787 
(Medium) 
UK / 
Caucasian 
aSAH PC PCR 91/116 Medium MMP-1 1G/2G  
MMP-3 5A/6A  
MMP-9 1562C>T  
Microsatellite 
Repeats (CA)n 
MMP-12 A-82G 
Krexet al. 
(2004) [14] 
3.780 
(Medium) 
Germany / 
Caucasian 
IA PC PCR 40/44 Medium MMP-9 59 C>T  
IVS4+3 G>T  
836 G>A  
IVS7+7 A>G  
1714 G>A  
1721 C>G  
1821 C>A  
2003 G>A  
2082 G>A  
*3 T>C  
*145 C>T  
Pannuet al. 
(2006) [15] 
3.443 
(Medium) 
USA /  
Black-
African-
American  
 
White-
European 
American 
 
sIA  PC Pyroseque-
ncing 
125/234 Medium MMP-2 -1306 C>T 
(rs243865) 
3307 G>A 
(hCV3225947) 
6447 G>C 
(rs17242319) 
10910 C>T 
(rs243847) 
MMP-9 -1562C>T 
(rs391242) 
Microsatellite 
repeats (CA)n 
1977 
C>T(rs39182253) 
7476 CT 
(rs20544) 
Kaplan et al. 
(2008) [16] 
3.942 
(Medium) 
USA /  
Black-
African-
American 
 
White-
HS PC Illumina 66/2696 Medium MMP-3 rs522616 
rs680753 
rs683878 
rs595840 
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European 
American 
 
MMP-9 rs2664538 
rs2250889 
rs2274756 
rs3918262 
Szczudlik et al. 
(2010) [17] 
0.747 
(Low) 
Poland / 
Caucasian 
HS PC PCR 211/212 Medium MMP-9 -1562 C/T 
(rs391242) 
Low et al. 
(2011) [18] 
2.487 (Low) Japan / 
Japanese 
IA PC PCR 2050/ 
1835 
Low MMP-2 rs243847 
rs243865 
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Table 2. STREGA scoring. M:medium, L:low 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q
u
es
ti
o
n
 
P
et
er
s 
(1
9
9
9
) 
Y
o
o
n
 (
1
9
9
9
) 
Z
h
a
n
g
 
(2
0
0
1
) 
K
re
x 
(2
0
0
4
) 
P
a
n
n
u
 
(2
0
0
6
) 
K
a
p
la
n
 
(2
0
0
8
) 
S
zc
zu
d
li
k
 
(2
0
1
0
) 
L
o
w
 (
2
0
1
1
) 
S
co
re
 (
%
) 
Title and abstract 1 Yes No Yes Yes Yes Yes Yes Yes 7 (77.7) 
Introduction   
2 Yes Yes Yes Yes Yes Yes Yes Yes 8 (100) 
3 No No Yes No No Yes No Yes 3 (33.3) 
Methods   
4 Yes Yes Yes Yes Yes Yes Yes Yes 8 (88.8) 
5 Yes Yes Yes Yes Yes Yes Yes Yes 8 (88.8) 
6 Yes Yes Yes No No Yes Yes No 5(55.5) 
7 No No No No No Yes Yes Yes 3 (33.3) 
8a Yes Yes Yes No Yes No No No 5 (55.5) 
9 No No No No Yes No No No 1 (11.1) 
10 No No No Yes No No Yes No 2 (22.2) 
11 Yes No Yes No No Yes Yes No 4 (44.4) 
12 No No No No No No No No 0 (0) 
Results   
13a No No No No No No No No 0 (0) 
14a No No No Yes No No No No 1 (11.1) 
15a No Yes Yes No No Yes Yes No 5(55.5) 
16 No No No No No No Yes No 1 (11.1) 
17 No No No No No No No No 0 (0) 
Discussion   
18 Yes No No Yes Yes Yes Yes Yes 7 (77.7) 
19 No Yes No Yes No Yes Yes No 4 (44.4) 
20 Yes No Yes No Yes Yes Yes Yes 6 (66.6) 
21 No No No No No No No No 0 (0) 
Other Information   
22 Yes Yes Yes Yes Yes No Yes No 7 (77.7) 
Score (Quality)  10 (M) 8 (M) 11 (M) 9 (M) 9 (M) 12 (M) 14 (M) 7 (L)  
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Figure 1. Flowchart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records identified through 
database searching 
(n = 63) 
Sc
re
en
in
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In
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u
d
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El
ig
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Id
en
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n
 
Additional records identified 
through other sources 
(n =  1 ) 
Records after duplicates removed 
(n = 30) 
Records screened 
(n =30) 
Records excluded 
Irrelevant title and/or abstract 
(n =13) 
Full-text articles assessed 
for eligibility 
(n =17) 
Full-text articles excluded, with reasons 
(9) 
Irrelevant full text (2) 
No control groups (2) 
Irrelevant methodology (5) 
Studies included in 
qualitative synthesis 
(n =8) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 7) 
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